Blood pressure reducing medications containing valsartam, an active ingredient produced by China's Zhejiang Huahai Pharmaceuticals, are being recalled in Lithuania as they may contain impurities capable of causing cancer.
© DELFI / Karolina Pansevič

Žydrūnas Martinėnas, deputy director of Lithuania's State Medicines Control Agency, told BNS Lithuania that the potential risk of the identified impurities is being assessed by the European Medicines Agency.

In his words, there are market alternatives with the same active ingredient to the recalled medications.

"New medications should be prescribed by the doctor," Martinėnas told BNS Lithuania.

The medications might have been contaminated with impurities during the manufacturing process, the Lithuania's State Medicines Control Agency said.

BNS
It is prohibited to copy and republish the text of this publication without a written permission from UAB „BNS“.

Hotel in Vilnius succeeded in prestigious Surface Travel Awards

The 17th-century mansion-turned-hotel located in Vilnius Old Town was named the winner in the large...

Actors and director get fines for 'church show'

Three actors and a director have been fined in Lithuania for disturbing a religious service at a...

Head of Holocaust memorial would like info to be available in Lithuanian as well

Avner Shalev, chairman of the Jerusalem-based Yad Vashem , the World Holocaust Remembrance Center,...

2020: The Year of Chiune Sugihara

Next year will mark the 80th anniversary of the Japanese diplomat’s noble work while residing in...

Czeslaw Milosz stairs unveiled in Krakow in 2nd such commemorative project after Vilnius

The Stairs of Czeslaw Milosz have been unveiled in Krakow to mark 15 years since the...